IMARC Group’s latest research report, titled “Global Synthetic Biology Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
The global synthetic biology market reached a value of US$ 11.17 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 32.93 Billion by 2027, exhibiting a CAGR of 18.60% during 2022-2027.
Synthetic biology refers to a field of research that includes the fabrication and designing of new biological beings, such as genetic circuits, enzymes and cells or redesigning organisms for important motives by engineering them to have distinctive qualities. It integrates the chemical synthesis of deoxyribonucleic acid (DNA) with genomics to allow the researchers to produce cataloged DNA sequences and collect them into new genomes. It aids in enhancing the environment by devising original ways to diminish pollution, making industrial procedures for chemical synthesis viable, and eliminating the need for damaging farming practices by making enhanced fertilizers.
Request a PDF Sample Copy for more detailed market insights:– https://www.imarcgroup.com/synthetic-biology-market/requestsample
Important Attribute and highlights of the Report:
- Detailed analysis of the global market share
- Market Segmentation by product, technology, application and region.
- Historical, current, and projected size of the market in terms of volume and value
- Latest industry trends and developments
- Competitive Landscape for Synthetic Biology Market
- Strategies of major players and product offerings
The primary factor driving the market is the refinement in the speed and cost of DNA synthesis, which has enabled scientists to design and synthesize modified bacterial chromosomes and bio-based specialty chemicals. Additionally, the rising investments in synthetic biology and its employment in the healthcare sector assist in upgrading diagnosis and developing finer treatment options for various diseases without causing any side effects is propelling the market growth.
Besides this, the extensive usage of genetically engineered viruses to amend defective genes of patients with inherited diseases like epidermolysis bullosa or severe combined immune deficiency (SCID) is catalyzing the market growth. Furthermore, the tools for performing synthetic biology are becoming reachable and the accessibility of the internet allows ideas to be freely reciprocated, which is catalyzing the market growth. Moreover, the remarkable growth in the healthcare sector and the increasing number of synthetic biology research institutions worldwide are creating a positive market outlook.
Key Players Included in Global Research Report:
- Agilent Technologies Inc.
- Amyris Inc.
- Codexis Inc.
- Danaher Corporation
- Eurofins Scientific
- GenScript Biotech Corporation
- Illumina Inc.
- Merck KGaA
- New England Biolabs
- Synthego Corporation
- Thermo Fisher Scientific Inc.
- Twist Bioscience
- Viridos Inc.
Do you know more information, Contact to our analyst at– https://www.imarcgroup.com/synthetic-biology-market
COVID-19 Impact on Market: (Positive Impact)
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Market Segmentation:
Breakup by Product:
- Oligonucleotide/Oligo Pools and Synthetic DNA
- Enzymes
- Cloning Technologies Kits
- Xeno-nucleic Acids
- Chassis Organism
Breakup by Technology:
- NGS Technology
- PCR Technology
- Genome Editing Technology
- Bioprocessing Technology
- Others
Breakup by Application:
- Healthcare
- Clinical
- Non-Clinical/Research
- Non-Healthcare
- Biotech Crops
- Specialty Chemicals
- Bio-Fuels
- Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
TOC for the Synthetic Biology Market Research Report:
- Preface
- Scope and Methodology
- Executive Summary
- Introduction
- Global Synthetic Biology Market
- SWOT Analysis
- Value Chain Analysis
- Price Analysis
- Competitive Landscape
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800